The Human Epidermal Growth Factor Receptor 2 (HER2) gene is amplified or overexpressed in around twenty to twenty-five percent of BC patients, which is linked with a higher risk of recurrence and a poor prognosis [127]. Here, ERBB2 is linked to breast cancer.